Mirae Asset Global Etfs Holdings Ltd. 4 D Molecular Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 24,749 shares of FDMT stock, worth $199,724. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,749Holding current value
$199,724% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FDMT
# of Institutions
152Shares Held
57.3MCall Options Held
55.6KPut Options Held
167K-
Ra Capital Management, L.P. Boston, MA5.1MShares$41.1 Million1.61% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$39.5 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$35.5 Million10.13% of portfolio
-
Goldman Sachs Group Inc New York, NY4.13MShares$33.4 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.06MShares$32.8 Million2.8% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $261M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...